Video

ecancer's extensive video archive features interviews, panel discussions and conference coverage on almost every topic in oncology.

The role of curative neoadjuvant treatment in certain cancer types

Dr Arthur Gregory Lui - Metro Davao Medical Research Center, Davao del Sur, Philippines
The role of curative neoadjuvant treatment in certain cancer types ( Dr Arthur Gregory Lui - Metro Davao Medical Research Center, Davao del Sur, Philippines )
4 Apr 2023

The pros and cons of breast IORT and ultra hypofractionation (FR)

Dr Sofia Rivera - Institut Gustave Roussy, Villejuif, France
The pros and cons of breast IORT and ultra hypofractionation (FR) ( Dr Sofia Rivera - Institut Gustave Roussy, Villejuif, France )
4 Apr 2023

SOFT study: Clinical relevance of genomic alterations in premenopausal HR+, HER2- early breast cancer

Prof Sherene Loi - Peter MacCallum Cancer Centre, Melbourne, Australia
SOFT study: Clinical relevance of genomic alterations in premenopausal HR+, HER2- early breast cancer ( Prof Sherene Loi - Peter MacCallum Cancer Centre, Melbourne, Australia )
28 Mar 2023

CG0070 plus pembro shows promising efficacy in NMIBC unresponsive to BCG

Dr Roger Li - Moffitt Cancer Center, Tampa, USA
CG0070 plus pembro shows promising efficacy in NMIBC unresponsive to BCG ( Dr Roger Li - Moffitt Cancer Center, Tampa, USA )
22 Mar 2023

Choosing wisely in multiple myeloma

Dr Bishesh Poudyal - Civil Service Hospital, Kathmandu, Nepal
Choosing wisely in multiple myeloma ( Dr Bishesh Poudyal - Civil Service Hospital, Kathmandu, Nepal )
20 Mar 2023

Upfront [177Lu]Lu-PSMA-617 radioligand therapy prior to radical prostatectomy in men with HR PC

Dr Renu Eapen - Peter MacCallum Cancer Centre, Melbourne, Australia
Upfront [177Lu]Lu-PSMA-617 radioligand therapy prior to radical prostatectomy in men with HR PC ( Dr Renu Eapen - Peter MacCallum Cancer Centre, Melbourne, Australia )
16 Mar 2023

Complete biochemical response below 0.1 ng/ml predicts long-term therapy-free survival via PSMA-radioguided surgery

Prof Tobias Maurer - Martini-Klinik Prostate Cancer Center, Hamburg, Germany
Complete biochemical response below 0.1 ng/ml predicts long-term therapy-free survival via PSMA-radioguided surgery ( Prof Tobias Maurer - Martini-Klinik Prostate Cancer Center, Hamburg, Germany )
16 Mar 2023

Diagnostic performance of 18F-rhPSMA-7.3 PET in newly diagnosed unfavourable intermediate to very high-risk prostate cancer

Prof Tobias Maurer - Martini-Klinik Prostate Cancer Center, Hamburg, Germany
Diagnostic performance of 18F-rhPSMA-7.3 PET in newly diagnosed unfavourable intermediate to very high-risk prostate cancer ( Prof Tobias Maurer - Martini-Klinik Prostate Cancer Center, Hamburg, Germany )
16 Mar 2023

Pembro monotherapy for participants with BCG–unresponsive HR NMIBC shows anti-tumour activity

Prof Andrea Necchi - The Vita-Salute San Raffaele University, Milan, Italy
Pembro monotherapy for participants with BCG–unresponsive HR NMIBC shows anti-tumour activity ( Prof Andrea Necchi - The Vita-Salute San Raffaele University, Milan, Italy )
16 Mar 2023

Digital rectal examination is not useful as a solitary screening tool for prostate cancer in young men

Prof Peter Albers - Heinrich-Heine-University Düsseldorf, Düsseldorf, Germany
Digital rectal examination is not useful as a solitary screening tool for prostate cancer in young men ( Prof Peter Albers - Heinrich-Heine-University Düsseldorf, Düsseldorf, Germany )
16 Mar 2023

Single intensive screening intervention using PSA and Stockholm3 in combination might reduce prostate cancer mortality

Prof Peter Albers - Heinrich-Heine-University Düsseldorf, Düsseldorf, Germany
Single intensive screening intervention using PSA and Stockholm3 in combination might reduce prostate cancer mortality ( Prof Peter Albers - Heinrich-Heine-University Düsseldorf, Düsseldorf, Germany )
16 Mar 2023

Intravesical IO using durvalumab shows promising results for patients with high risk NMIBC after BCG failure

Dr Charalampos Fragkoulis - General Hospital of Athens, Athens, Greece
Intravesical IO using durvalumab shows promising results for patients with high risk NMIBC after BCG failure ( Dr Charalampos Fragkoulis - General Hospital of Athens, Athens, Greece )
16 Mar 2023